Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
1994 Consensus Conference on Acute GVHD Grading.
1995 • 4,743 citations
Chronic graft-versus-host syndrome in man
1980 • 2,438 citations
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 • 2,026 citations
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
1990 • 1,544 citations
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
1997 • 1,290 citations
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
1997 • 1,180 citations
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase
1988 • 887 citations
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease
1995 • 772 citations
Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous Leukemia
1986 • 675 citations
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994 • 510 citations
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse
1994 • 358 citations
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose
1993 • 356 citations
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
1995 • 341 citations
Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow Transplant
1998 • 328 citations
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
2000 • 301 citations
Characteristics of accelerated disease in chronic myelogenous leukemia
1988 • 280 citations
Complete Remission of Accelerated Phase Chronic Myeloid Leukemia by Treatment With Leukemia-Reactive Cytotoxic T Lymphocytes
1999 • 277 citations
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA
1984 • 265 citations
Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units
1997 • 245 citations
T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASE
1987 • 223 citations
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
2000 • 194 citations
SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL
1994 • 174 citations
T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
1995 • 167 citations
T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect
1998 • 159 citations
USE OF DNA RESTRICTION FRAGMENT LENGTH POLYMORPHISMS TO DOCUMENT MARROW ENGRAFTMENT AND MIXED HEMATOPOIETIC CHIMERISM FOLLOWING BONE MARROW TRANSPLANTATION
1987 • 133 citations
Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions
1999 • 123 citations
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
1997 • 87 citations
Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors
1998 • 75 citations
Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL.
1996 • 63 citations
Donor lymphocyte infusions
1996 • 62 citations
GRAFT-VERSUS-MYELOID LEUKEMIA RESPONSES FOLLOWING SYNGENEIC AND ALLOGENEIC BONE MARROW TRANSPLANTATION
1994 • 61 citations
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation
1992 • 56 citations
Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
1991 • 41 citations
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation
2000 • 34 citations
Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
1995 • 20 citations
Cited By (0)
No citing papers found in database